nilla, Author at European Medical Journal - Page 16 of 20

Taking a bet on blockchain

GOLD explores what the pharmaceutical industry’s future might look like with the adoption of blockchain technology within its key functions.

Treatment milestone for diabetes in pregnancy

After positive study results, metformin-based anti-diabetic medication from Merck has received a label extension for use throughout pregnancy. Find out more.

Digital health, biotech and the metaverse

New podcast episode about digital health apps and the metaverse. Guests Liz Ashall-Payne (ORCHA) and Dario Safaric (NEXT Pharma). Listen now!

Rare disease action plan published

A new action plan for rare diseases has been published by the Department of Health and Social Care to mark Rare Diseases Day.

Spoonful of apps

GOLD showcases some standout apps created, or harnessed by, the pharma industry.

Bridging the digital health divide

Technology has redefined the exchange of health information. Find out how the pharma industry can help patients build confidence about digital health tools.

Nurturing home-grown innovation in Europe

Europe is a front runner for pharmaceutical research and thought leadership Find out in what measure this is translating into home-grown innovation.

Sanofi and GSK seek COVID-19 vaccine approval

Sanofi and GSK are seeking regulatory approval for their adjuvanted protein-based COVID-19 vaccine, as a primary two-dose series and booster dose.

Reacting to supply chain risks

The pharmaceutical supply chain is vulnerable to adverse events, and the pandemic has served as a reminder of how these networks can be tested. The industry has learned tough lessons from COVID-19 that must be translated into modernisation and improvements

Wayne Best, VMLY&R

Innovative tech, pharma supply chains and more

Marc and Helena chat with Wayne Best, Chief Creative Officer, VMLY&R, about his ‘I Will Always Be Me’ project for patients with motor neurone disease. Listen now!